InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.06
(
-0.08%
)
Bitcoin
66,565.00
(
-0.11%
)
Post# of 252209
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Saturday, 06/14/2008 12:18:25 PM

Saturday, June 14, 2008 12:18:25 PM

Post# of 252209
BLYS antagonists--I have noticed that Biogen and Genentech no longer list the BR3-soluble receptor/BLYS antagonist on their current pipeline list. Also the anti-BR3 antibody is no longer on the Genentech pipeline list. Does anybody have any updates on these programs? Have they been discontinued? or are they running in stealth mode? Comments appreciated.

biophud
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up